Champions Oncology
CSBR
CSBR
30 hedge funds and large institutions have $50.4M invested in Champions Oncology in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
3% less funds holding
Funds holding: 31 → 30 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
30
Holding in Top 10
1
Calls
$1.83M
Puts
–
Top Buyers
| 1 | +$131K | |
| 2 | +$70.4K | |
| 3 | +$23.1K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$21.8K |
Top Sellers
| 1 | -$169K | |
| 2 | -$143K | |
| 3 | -$58.6K | |
| 4 |
MTWM
Masso Torrence Wealth Management
Marlton,
New Jersey
|
-$8K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$7.43K |